Home›Companies›Industrial & Robotics›Reticle Biosystems

Reticle Biosystems, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Jul 14, 2026·Suggest an edit

About Reticle Biosystems

Reticle Biosystems is a private company based in San Francisco, California, incorporated in 2026 in Delaware. It has reported $1,000,000 raised in one offering on Form D since July 2026. Its chief executive is James Che.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 8, 2026Jul 14, 2026$1,000,000fully sold1$1.0MOptions, Securities on exercise, Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Reticle Biosystems's Form D filed Jul 14, 2026.

JC
James Che
Chief Executive Officer and director

Sources

  1. SECReticle Biosystems, Inc. filing history